CLHIA-ACCAP

CLHIA Report on Prescription Drug Policy

Issue link: http://clhia.uberflip.com/i/406567

Contents of this Issue

Navigation

Page 8 of 44

3 administrators of the vast majority of drug benefits plans in Canada, we have a responsibility to employers and individual Canadians to constructively seek improvements to the current system. In addition, the industry is unique amongst payers in that we operate on a national basis, which gives us a strong and deep pan-Canadian perspective on the issue of drug coverage reform. The ultimate goal from a policy perspective must be to ensure that Canadians have access to the drugs they need without undue financial hardship as a result of prescription drug costs. 2. GUIDING PRINCIPLES This policy paper presents actionable recommendations to help assist in the development of sound prescription drug policy. The recommendations are grounded in fundamental principles, as set out below, which we believe should guide the policy decision-making process. 1. Accessibility: All Canadians should have access to proven/effective prescription drugs when they need them. 2. Affordability: No Canadian should suffer undue financial hardship because of the cost of the prescription drugs they need. 3. Sustainability: The prescription drug system in Canada must be financially sustainable over the long-term. 4. Patient Safety and Education: Patient safety is paramount – the drugs Canadians use need to be safe and effective for their condition. Education is critical to enable Canadians to make informed decisions. 5. Fairness: All Canadians should have access to prescription drugs at the same cost whether being paid for by public or private plans, or directly out-of-pocket.

Articles in this issue

view archives of CLHIA-ACCAP - CLHIA Report on Prescription Drug Policy